nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case with isolated growth hormone deficiency caused by compound heterozygous mutations in GH-1: A novel missense mutation in the initiation codon and a 7.6kb deletion
|
Hayashi, Yoshitaka |
|
2007 |
53-54 |
3 |
p. 249-253 5 p. |
artikel |
2 |
Acute resistance exercise stimulates sex-specific dimeric immunoreactive growth hormone responses
|
Luk, Hui Ying |
|
2015 |
53-54 |
3 |
p. 136-140 5 p. |
artikel |
3 |
Aging phenotype and its relationship with IGF-I gene promoter polymorphisms in elderly people living in Catalonia
|
Mora, Mireia |
|
2011 |
53-54 |
3 |
p. 174-180 7 p. |
artikel |
4 |
Aims & Scope/Editorial Board
|
|
|
2009 |
53-54 |
3 |
p. i- 1 p. |
artikel |
5 |
Aims & Scope/Editorial Board
|
|
|
2010 |
53-54 |
3 |
p. i- 1 p. |
artikel |
6 |
Aims & Scope/Editorial Board
|
|
|
2006 |
53-54 |
3 |
p. i- 1 p. |
artikel |
7 |
Aims; Scope/Editorial Board
|
|
|
2004 |
53-54 |
3 |
p. i- 1 p. |
artikel |
8 |
Aims & Scope/Editorial Board
|
|
|
2008 |
53-54 |
3 |
p. i- 1 p. |
artikel |
9 |
Aims&scope/Editorial Boardi
|
|
|
2007 |
53-54 |
3 |
p. i- 1 p. |
artikel |
10 |
A liver specific gene that is expressed in growth hormone transgenic mice and in normal female mice as a function of age
|
Tiong, Jean D.R. |
|
2006 |
53-54 |
3 |
p. 145-156 12 p. |
artikel |
11 |
Alternative splicing of insulin-like growth factor I mRNA is developmentally regulated in the rat and mouse with preferential exon 2 usage in the mouse
|
Lin, Wen-wen |
|
1998 |
53-54 |
3 |
p. 225-233 9 p. |
artikel |
12 |
Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy
|
Fernholm, R. |
|
2009 |
53-54 |
3 |
p. 206-211 6 p. |
artikel |
13 |
A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men
|
Svensson, J. |
|
2000 |
53-54 |
3 |
p. 118-126 9 p. |
artikel |
14 |
An N-terminal fragment of insulin-like growth factor binding protein-3 (IGFBP-3) induces apoptosis in human prostate cancer cells in an IGF-independent manner
|
Shahjee, H. |
|
2008 |
53-54 |
3 |
p. 188-197 10 p. |
artikel |
15 |
An ocular view of the IGF–IGFBP system
|
Nguyen, Dung V. |
|
2013 |
53-54 |
3 |
p. 45-52 8 p. |
artikel |
16 |
A novel GH-1 gene mutation (GH-P59L) causes partial GH deficiency type II combined with bioinactive GH syndrome
|
Petkovic, Vibor |
|
2011 |
53-54 |
3 |
p. 160-166 7 p. |
artikel |
17 |
Appearance of insulin and insulin-like growth factor-I (IGF-I) receptors throughout the ontogeny of brown trout (Salmo trutta fario)
|
Maestro, M.A. |
|
1998 |
53-54 |
3 |
p. 195-204 10 p. |
artikel |
18 |
A quantitative PCR measurement of messenger RNA expression of IGF-I, IGF-II and IGFBP-5 in human skeletal muscle
|
Schimke, Jill M.Coenen |
|
1999 |
53-54 |
3 |
p. 179-186 8 p. |
artikel |
19 |
Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk
|
Belobrajdic, Damien P. |
|
2008 |
53-54 |
3 |
p. 198-204 7 p. |
artikel |
20 |
Assessment of hydration by means of bioelectrical impedance and arm muscle area during growth hormone (GH) replacement therapy: A prospective study of 130 GH-deficient patients
|
Badre-Esfahani, Sara |
|
2007 |
53-54 |
3 |
p. 227-233 7 p. |
artikel |
21 |
Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus
|
Akturk, Mujde |
|
2007 |
53-54 |
3 |
p. 186-193 8 p. |
artikel |
22 |
Associations of the IGF/IGFBP axis and respiratory diseases in neonatal patients during the first 6 months of life
|
Hübler, Axel |
|
2006 |
53-54 |
3 |
p. 185-192 8 p. |
artikel |
23 |
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome
|
Sode-Carlsen, Rasmus |
|
2010 |
53-54 |
3 |
p. 179-184 6 p. |
artikel |
24 |
Cardiac IGF-I manipulation by growth hormone following myocardial infarction
|
Matthews, K.G |
|
2004 |
53-54 |
3 |
p. 251-260 10 p. |
artikel |
25 |
Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II)
|
Binder, G. |
|
2007 |
53-54 |
3 |
p. 242-248 7 p. |
artikel |
26 |
Characterisation of insulin-like growth factor receptors and insulin receptors in the human placenta using lectin affinity methods
|
Masnikosa, Romana |
|
2006 |
53-54 |
3 |
p. 174-184 11 p. |
artikel |
27 |
Circulating IGF-I is associated with fitness and health outcomes in a population of 846 young healthy men
|
Nindl, Bradley C. |
|
2011 |
53-54 |
3 |
p. 124-128 5 p. |
artikel |
28 |
Circulating insulin-like growth factors (IGF-I and -II) and IGF binding proteins in divergently selected Fat or Lean chickens: effect of prolonged fasting
|
Beccavin, C. |
|
1999 |
53-54 |
3 |
p. 187-194 8 p. |
artikel |
29 |
Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes
|
Jeyaratnaganthan, Nilani |
|
2010 |
53-54 |
3 |
p. 185-191 7 p. |
artikel |
30 |
Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels
|
Temmerman, L. |
|
2010 |
53-54 |
3 |
p. 255-263 9 p. |
artikel |
31 |
Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients
|
Wassenaar, M.J.E. |
|
2010 |
53-54 |
3 |
p. 226-233 8 p. |
artikel |
32 |
Combination treatment with somatostatin analogues and pegvisomant in acromegaly
|
Neggers, S.J.C.M.M. |
|
2011 |
53-54 |
3 |
p. 129-133 5 p. |
artikel |
33 |
Consensus statement from an international collaborative
|
|
|
2007 |
53-54 |
3 |
p. 177-178 2 p. |
artikel |
34 |
Contrasting bone effects of temporary versus permanent IGFBP administration in rodents
|
Hoeflich, Andreas |
|
2008 |
53-54 |
3 |
p. 181-187 7 p. |
artikel |
35 |
Cyclic AMP agonists increase levels of insulin-like growth factor (IGF) binding protein-6 in PC12 rat phaeochromocytoma cells
|
Bach, Leon A. |
|
1998 |
53-54 |
3 |
p. 265-271 7 p. |
artikel |
36 |
Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1β in vitro
|
Barreca, A. |
|
1998 |
53-54 |
3 |
p. 217-223 7 p. |
artikel |
37 |
Detection of growth hormone abuse in sport
|
Powrie, J.K. |
|
2007 |
53-54 |
3 |
p. 220-226 7 p. |
artikel |
38 |
Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes
|
Beauloye, V. |
|
1999 |
53-54 |
3 |
p. 205-211 7 p. |
artikel |
39 |
Diagnosis and management of growth hormone deficiency in childhood and adolescence
|
Sizonenko, Pierre C |
|
2001 |
53-54 |
3 |
p. 137-165 29 p. |
artikel |
40 |
Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells
|
Conover, Cheryl A. |
|
2008 |
53-54 |
3 |
p. 213-220 8 p. |
artikel |
41 |
Dose-dependent changes in body composition during growth hormone (GH) treatment in Japanese patients with adult GH deficiency: A randomized, placebo-controlled trial
|
Chihara, Kazuo |
|
2010 |
53-54 |
3 |
p. 205-211 7 p. |
artikel |
42 |
Editorial
|
Sönksen, Peter |
|
2000 |
53-54 |
3 |
p. 107-110 4 p. |
artikel |
43 |
Editorial Board
|
|
|
2002 |
53-54 |
3 |
p. i- 1 p. |
artikel |
44 |
Editorial board
|
|
|
2005 |
53-54 |
3 |
p. i- 1 p. |
artikel |
45 |
Editorial Board
|
|
|
2015 |
53-54 |
3 |
p. i- 1 p. |
artikel |
46 |
Editorial Board
|
|
|
2013 |
53-54 |
3 |
p. i- 1 p. |
artikel |
47 |
Editorial Board
|
|
|
2011 |
53-54 |
3 |
p. i- 1 p. |
artikel |
48 |
Effect of circulating growth hormone on muscle IGF-I protein concentration in female mice with growth hormone receptor gene disruption
|
Kraemer, William J. |
|
2009 |
53-54 |
3 |
p. 242-244 3 p. |
artikel |
49 |
Effect of environment on growth: Auxological and hormonal parameters in African and Italian children
|
Boschetti, Mara |
|
2009 |
53-54 |
3 |
p. 238-241 4 p. |
artikel |
50 |
Effects of growth hormone treatment in adults with Prader–Willi syndrome
|
Butler, M.G. |
|
2013 |
53-54 |
3 |
p. 81-87 7 p. |
artikel |
51 |
Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature
|
Guevara-Aguirre, Jaime |
|
2007 |
53-54 |
3 |
p. 261-264 4 p. |
artikel |
52 |
Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro
|
Mochizuki, Tomoko |
|
2006 |
53-54 |
3 |
p. 202-210 9 p. |
artikel |
53 |
Effects of lifestyle on plasma levels of the IGF system and the antioxidants coenzyme Q10 and vitamin E in Kenyan rural and urban populations
|
Theuri, G. |
|
2013 |
53-54 |
3 |
p. 68-75 8 p. |
artikel |
54 |
Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan’s syndrome
|
Tanriverdi, F. |
|
2005 |
53-54 |
3 |
p. 231-237 7 p. |
artikel |
55 |
Erratum
|
|
|
2001 |
53-54 |
3 |
p. 198-199 2 p. |
artikel |
56 |
Evidence for a decrease in cardiovascular risk factors following recombinant growth hormone administration in abstinent anabolic-androgenic steroid users
|
Graham, Michael R. |
|
2007 |
53-54 |
3 |
p. 201-209 9 p. |
artikel |
57 |
Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system
|
Hattori, Naoki |
|
2009 |
53-54 |
3 |
p. 187-197 11 p. |
artikel |
58 |
Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): Correlation with serum IGFBP-3 levels and growth in short children born small for gestational age
|
Kaay, D.C.M. van der |
|
2009 |
53-54 |
3 |
p. 198-205 8 p. |
artikel |
59 |
Genetic strategies for elucidating insulin-like growth factor action in bone
|
Clemens, Thomas L. |
|
2004 |
53-54 |
3 |
p. 195-199 5 p. |
artikel |
60 |
GH receptor blocker administration and muscle–tendon collagen synthesis in humans
|
Nielsen, Rie Harboe |
|
2011 |
53-54 |
3 |
p. 140-145 6 p. |
artikel |
61 |
Growth hormone administration can improve growth in glucocorticoid-injected rats without affecting the lymphocytopenic effect of the glucocorticoid
|
Ørtoft, G. |
|
1998 |
53-54 |
3 |
p. 251-264 14 p. |
artikel |
62 |
Growth hormone and adipose tissue: Beyond the adipocyte
|
Berryman, Darlene E. |
|
2011 |
53-54 |
3 |
p. 113-123 11 p. |
artikel |
63 |
Growth hormone binding protein and maternal body mass index in relation to placental growth hormone and insulin requirements during pregnancy in type 1 diabetic women
|
Fuglsang, Jens |
|
2005 |
53-54 |
3 |
p. 223-230 8 p. |
artikel |
64 |
Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction
|
Akin, Fulya |
|
2009 |
53-54 |
3 |
p. 252-255 4 p. |
artikel |
65 |
Growth hormone promotes proliferation of adult neurosphere cultures
|
McLenachan, S. |
|
2009 |
53-54 |
3 |
p. 212-218 7 p. |
artikel |
66 |
Growth hormone receptor d3-variant, insulin-like growth factor binding protein-1 –575G/A polymorphism and postnatal catch-up growth: Association with parameters of glucose homeostasis in former extremely low birth weight preterm infants
|
Schreiner, Felix |
|
2010 |
53-54 |
3 |
p. 201-204 4 p. |
artikel |
67 |
Growth hormone treatment and type 2 diabetes
|
Kohno, H. |
|
2001 |
53-54 |
3 |
p. 196-197 2 p. |
artikel |
68 |
GRS 2000 Abstracts
|
|
|
2000 |
53-54 |
3 |
p. 129-186 58 p. |
artikel |
69 |
Heterozygous mutation in the WSXWS equivalent motif of the growth hormone receptor in a child with poor response to growth hormone therapy
|
Tauber, M.T. |
|
1998 |
53-54 |
3 |
p. 211-216 6 p. |
artikel |
70 |
Hormonal and metabolic responses to repeated cycling sprints under different hypoxic conditions
|
Kon, Michihiro |
|
2015 |
53-54 |
3 |
p. 121-126 6 p. |
artikel |
71 |
Hypopituitarism following traumatic brain injury
|
Popovic, V. |
|
2005 |
53-54 |
3 |
p. 177-184 8 p. |
artikel |
72 |
Identification of N-linked oligosaccharides of rat insulin-like growth factor binding protein-4
|
Chelius, Dirk |
|
2002 |
53-54 |
3 |
p. 169-177 9 p. |
artikel |
73 |
IGFBP-6 five years on; not so ‘forgotten’?
|
Bach, Leon A. |
|
2005 |
53-54 |
3 |
p. 185-192 8 p. |
artikel |
74 |
IGFBP-2/PTEN: A critical interaction for tumours and for general physiology?
|
Zeng, Li |
|
2015 |
53-54 |
3 |
p. 103-107 5 p. |
artikel |
75 |
IGF-I, IGFBP-3 and ALS generation test in Turner syndrome
|
Pessoa de Queiroz, Andréa Noronha |
|
2007 |
53-54 |
3 |
p. 254-260 7 p. |
artikel |
76 |
IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function
|
Scheinowitz, Mickey |
|
2009 |
53-54 |
3 |
p. 280-282 3 p. |
artikel |
77 |
IGF-IR/ERK content and response to IGF-I and insulin in adipocytes from small for gestational age children
|
Iñiguez, German |
|
2009 |
53-54 |
3 |
p. 256-261 6 p. |
artikel |
78 |
IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes
|
Fukuoka, Hidenori |
|
2010 |
53-54 |
3 |
p. 212-219 8 p. |
artikel |
79 |
IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients
|
Nindl, Bradley C. |
|
2004 |
53-54 |
3 |
p. 245-250 6 p. |
artikel |
80 |
Impact of the GH–cortisol ratio on the age-dependent changes in body composition
|
Nass, R |
|
2002 |
53-54 |
3 |
p. 147-161 15 p. |
artikel |
81 |
Inactivation of insulin-like-growth factors diminished the anabolic effects of pregnancy-associated plasma protein-A (PAPP-A) on bone in mice
|
Phang, David |
|
2010 |
53-54 |
3 |
p. 192-200 9 p. |
artikel |
82 |
Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month’s treatment with supraphysiological doses of growth hormone
|
Ehrnborg, Christer |
|
2007 |
53-54 |
3 |
p. 234-241 8 p. |
artikel |
83 |
Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise: Responses of molecular mass variants
|
Kraemer, William J. |
|
2008 |
53-54 |
3 |
p. 238-244 7 p. |
artikel |
84 |
Insulin-like growth factor binding protein-4 expression is dependent on the carbohydrate in the media in HT-29 cells
|
Corkins, Mark R |
|
2002 |
53-54 |
3 |
p. 184-192 9 p. |
artikel |
85 |
Insulin-like growth factor binding protein-3 gene methylation and protein expression in gastric adenocarcinoma
|
Gigek, Carolina Oliveira |
|
2010 |
53-54 |
3 |
p. 234-238 5 p. |
artikel |
86 |
Insulin-like growth factor binding protein-5 in osteogenesis: Facilitator or inhibitor?
|
Mukherjee, Aditi |
|
2007 |
53-54 |
3 |
p. 179-185 7 p. |
artikel |
87 |
Insulin-like growth factor binding protein-3 is a novel mediator of apoptosis in insulin-secreting cells
|
Shim, Melanie L |
|
2004 |
53-54 |
3 |
p. 216-225 10 p. |
artikel |
88 |
Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis
|
Vasylyeva, Tetyana L. |
|
2005 |
53-54 |
3 |
p. 207-214 8 p. |
artikel |
89 |
Insulin-like growth factor-I (IGF-I): Solution properties and NMR chemical shift assignments near physiological pH
|
Kuang, Zhihe |
|
2009 |
53-54 |
3 |
p. 226-231 6 p. |
artikel |
90 |
Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African–American women
|
Kalla Singh, S. |
|
2010 |
53-54 |
3 |
p. 245-254 10 p. |
artikel |
91 |
Interleukin-5 potentiates the growth response of Caco-2 cells to IGF-II: A role in colonic carcinogenesis complicating ulcerative colitis?
|
Makins, Richard |
|
2005 |
53-54 |
3 |
p. 215-222 8 p. |
artikel |
92 |
Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin
|
Vindeløv, Signe Diness |
|
2011 |
53-54 |
3 |
p. 134-139 6 p. |
artikel |
93 |
Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly
|
Biermasz, Nienke R. |
|
2005 |
53-54 |
3 |
p. 200-206 7 p. |
artikel |
94 |
Is growth hormone stimulation testing in children still appropriate?
|
Gandrud, Laura M |
|
2004 |
53-54 |
3 |
p. 185-194 10 p. |
artikel |
95 |
Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease
|
Kuan, Ying |
|
2009 |
53-54 |
3 |
p. 219-225 7 p. |
artikel |
96 |
Lack of insulin-like growth factor binding protein-3 protease activation by venous cannulation
|
Gustafsson, S. |
|
2005 |
53-54 |
3 |
p. 238-242 5 p. |
artikel |
97 |
Lies, damn lies and statistics
|
Sonksen, Peter H. |
|
2005 |
53-54 |
3 |
p. 173-176 4 p. |
artikel |
98 |
Local feedback loop of ghrelin-GH in the pig ovary: Action on estradiol secretion, aromatase activity and cell apoptosis
|
Rak, Agnieszka |
|
2008 |
53-54 |
3 |
p. 221-227 7 p. |
artikel |
99 |
Long-term physical training increases liver IGF-I in diabetic rats
|
Leme, J.A.C.A. |
|
2009 |
53-54 |
3 |
p. 262-266 5 p. |
artikel |
100 |
Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults
|
Devin, Jessica K. |
|
2008 |
53-54 |
3 |
p. 253-263 11 p. |
artikel |
101 |
Maternal insulin-like growth factor 1 and 2 differentially affect the renin–angiotensin system during pregnancy in the guinea pig
|
Standen, Prue |
|
2015 |
53-54 |
3 |
p. 141-147 7 p. |
artikel |
102 |
MMP-2 in the left rat ventricle is increased by growth hormone
|
Brüel, Annemarie |
|
2006 |
53-54 |
3 |
p. 193-201 9 p. |
artikel |
103 |
Modulation of rat pituitary growth hormone by 670nm light
|
Hymer, W.C. |
|
2009 |
53-54 |
3 |
p. 274-279 6 p. |
artikel |
104 |
mRNA and protein localization of the IGF system during mouse embryonic development in areas with apoptosis
|
Kleffens, M.van |
|
1999 |
53-54 |
3 |
p. 195-204 10 p. |
artikel |
105 |
Muscle insulin-like growth factor-I (IGF-I) receptors in chickens with high or low body weight: effects of age and muscle fibre type
|
Oudin, A. |
|
1998 |
53-54 |
3 |
p. 243-250 8 p. |
artikel |
106 |
Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, -2 and -4
|
Brandt, Katrin |
|
2011 |
53-54 |
3 |
p. 167-173 7 p. |
artikel |
107 |
Ovine placental lactogen and human growth hormone bind to different regions of the same receptors
|
Longhi, S.A. |
|
1999 |
53-54 |
3 |
p. 157-164 8 p. |
artikel |
108 |
Perioperative treatment with human growth hormone down-regulates apoptosis and increases superoxide production in PMN from patients undergoing infrarenal abdominal aortic aneurysm repair
|
Decker, Dorothee |
|
2005 |
53-54 |
3 |
p. 193-199 7 p. |
artikel |
109 |
Peripheral growth hormone induces cell proliferation in the intact adult rat brain
|
David Åberg, N. |
|
2010 |
53-54 |
3 |
p. 264-269 6 p. |
artikel |
110 |
Pharmacodynamic evaluation of a PEGylated analogue of human growth hormone releasing factor in rats and pigs
|
D'Antonio, M |
|
2004 |
53-54 |
3 |
p. 226-234 9 p. |
artikel |
111 |
Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers
|
Garcia, José M. |
|
2009 |
53-54 |
3 |
p. 267-273 7 p. |
artikel |
112 |
Phosphatidylinositol 3-kinase (PI3K) signalling regulates insulin-like-growth factor binding protein-2 (IGFBP-2) production in human adipocytes
|
Wilhelm, Franziska |
|
2015 |
53-54 |
3 |
p. 115-120 6 p. |
artikel |
113 |
Pituitary choriocarcinoma in an adolescent male: Tumor-derived CG and GH delay diagnosis
|
Wildi-Runge, S. |
|
2011 |
53-54 |
3 |
p. 181-184 4 p. |
artikel |
114 |
Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency
|
Rizzo, Manfredi |
|
2008 |
53-54 |
3 |
p. 264-266 3 p. |
artikel |
115 |
Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP
|
Glad, Camilla A.M. |
|
2010 |
53-54 |
3 |
p. 270-273 4 p. |
artikel |
116 |
Recommendations for nomenclature of the insulin-like growth factor binding protein (IGFBP) superfamily
|
Baxter, R.C. |
|
1998 |
53-54 |
3 |
p. 273-274 2 p. |
artikel |
117 |
Reduced GLUT1 expression in Igf1–/– null oocytes and follicles
|
Zhou, J. |
|
2000 |
53-54 |
3 |
p. 111-117 7 p. |
artikel |
118 |
Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: Results of the Study of Health in Pomerania (SHIP)
|
Friedrich, Nele |
|
2008 |
53-54 |
3 |
p. 228-237 10 p. |
artikel |
119 |
Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor
|
Makimura, H. |
|
2011 |
53-54 |
3 |
p. 155-159 5 p. |
artikel |
120 |
Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3
|
Safarinejad, Mohammad Reza |
|
2011 |
53-54 |
3 |
p. 146-154 9 p. |
artikel |
121 |
Rskα-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and blood: Impact on regeneration, denervation and muscular dystrophy
|
Shavlakadze, T. |
|
2006 |
53-54 |
3 |
p. 157-173 17 p. |
artikel |
122 |
Safety aspects of pharmacological GH therapy in adults
|
Carroll, Paul V. |
|
2001 |
53-54 |
3 |
p. 166-172 7 p. |
artikel |
123 |
Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature
|
Gascoin-Lachambre, G. |
|
2007 |
53-54 |
3 |
p. 194-200 7 p. |
artikel |
124 |
short-term administration of insulin-like growth factor I (IGF-1) does not induce myocardial IGF-1 resistance
|
Ren, Jun |
|
2002 |
53-54 |
3 |
p. 162-168 7 p. |
artikel |
125 |
Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction
|
Tivesten, Å. |
|
2001 |
53-54 |
3 |
p. 187-195 9 p. |
artikel |
126 |
Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone
|
Wu, Zida |
|
2010 |
53-54 |
3 |
p. 239-244 6 p. |
artikel |
127 |
Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis
|
Conover, Cheryl A |
|
2002 |
53-54 |
3 |
p. 178-183 6 p. |
artikel |
128 |
Suppressors of cytokine signalling and regulation of growth hormone action
|
Greenhalgh, Christopher J. |
|
2004 |
53-54 |
3 |
p. 200-206 7 p. |
artikel |
129 |
Survival and cellular immune functions in septic mice treated with growth hormone (GH) and insulin-like growth factor-I (IGF-I)
|
Schmitz, Daniel |
|
2008 |
53-54 |
3 |
p. 245-252 8 p. |
artikel |
130 |
Systemic response of the GH/IGF-I axis in timely versus delayed fracture healing
|
Weiss, Stefan |
|
2008 |
53-54 |
3 |
p. 205-212 8 p. |
artikel |
131 |
The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatment
|
Roemmler, J. |
|
2009 |
53-54 |
3 |
p. 245-251 7 p. |
artikel |
132 |
The effect of acute insulin-like growth factor-II administration on glucose metabolism in the rat
|
Burvin, Ram |
|
1998 |
53-54 |
3 |
p. 205-210 6 p. |
artikel |
133 |
The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy
|
O’Neal, D.N. |
|
1999 |
53-54 |
3 |
p. 165-173 9 p. |
artikel |
134 |
The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides
|
Renehan, Andrew G. |
|
2007 |
53-54 |
3 |
p. 210-219 10 p. |
artikel |
135 |
The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young men
|
Velloso, C.P. |
|
2013 |
53-54 |
3 |
p. 76-80 5 p. |
artikel |
136 |
The growth hormone receptor associates with Jak1, Jak2 and Tyk2 in human liver
|
Hellgren, Gunnel |
|
1999 |
53-54 |
3 |
p. 212-218 7 p. |
artikel |
137 |
The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children
|
Hellgren, G. |
|
2015 |
53-54 |
3 |
p. 127-135 9 p. |
artikel |
138 |
The IGF-II enigma
|
Holly, Jeff M.P. |
|
1998 |
53-54 |
3 |
p. 183-184 2 p. |
artikel |
139 |
The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency
|
Deepak, D. |
|
2010 |
53-54 |
3 |
p. 220-225 6 p. |
artikel |
140 |
The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment
|
Zimmermann-Belsing, T. |
|
2004 |
53-54 |
3 |
p. 235-244 10 p. |
artikel |
141 |
The robustness of diagnostic tests for GH deficiency in adults
|
Andersen, Marianne |
|
2015 |
53-54 |
3 |
p. 108-114 7 p. |
artikel |
142 |
The role of growth hormone in fetal development
|
Waters, M.J |
|
2002 |
53-54 |
3 |
p. 137-146 10 p. |
artikel |
143 |
The role of human growth hormone's C-terminal disulfide bridge
|
Junnila, R.K. |
|
2013 |
53-54 |
3 |
p. 62-67 6 p. |
artikel |
144 |
The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy
|
Sharples, Adam P. |
|
2013 |
53-54 |
3 |
p. 53-61 9 p. |
artikel |
145 |
The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues
|
Dubreuil, P |
|
2001 |
53-54 |
3 |
p. 173-186 14 p. |
artikel |
146 |
Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption
|
Svensson, Johan |
|
2004 |
53-54 |
3 |
p. 207-215 9 p. |
artikel |
147 |
Thyroid hormones are involved in insulin-like growth factor-I (IGF-I) production by stimulating hepatic growth hormone receptor (GHR) gene expression in the chicken
|
Tsukada, A. |
|
1998 |
53-54 |
3 |
p. 235-242 8 p. |
artikel |
148 |
Tumor necrosis factor α and interferon γ– induced cell growth arrest is mediated via insulin-like growth factor binding protein-3
|
Katz, J |
|
1999 |
53-54 |
3 |
p. 174-178 5 p. |
artikel |
149 |
Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH–IGF) axis gene expression in human fetal epiphyseal chondrocytes
|
Fernández-Cancio, M. |
|
2009 |
53-54 |
3 |
p. 232-237 6 p. |
artikel |
150 |
What is the function of IGF-II in postnatal life? Answers from transgenic mouse models
|
Wolf, Eckhard |
|
1998 |
53-54 |
3 |
p. 185-193 9 p. |
artikel |